Loading patent
US12459926B2 · 11/04/2025
The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRα selectivity while maintaining good THRβ agonistic activity, thereby improving properties of the finished drug.
The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRα selectivity while maintaining good THRβ agonistic activity, thereby improving properties of the finished drug.
No articles yet — metadata is still available from the registry.
0 replies · cite patents with ^
Join the discussion
Continue with GoogleNo comments yet.
